Use of VEGFR-2 targeted ultrasound contrast agent for the early evaluation of response to sorafenib in a mouse model of hepatocellular carcinoma.
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Fabio Piscaglia Sara Marinelli Marco Baron Toaldo Maddalena Milazzo |
| Publication date | February 1, 2015 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |